Atb Cap Markets Comments on Organigram Q1 Earnings

Organigram Holdings Inc. (TSE:OGIFree Report) – Atb Cap Markets issued their Q1 2025 earnings per share (EPS) estimates for Organigram in a research report issued to clients and investors on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes expects that the company will post earnings per share of ($0.03) for the quarter. The consensus estimate for Organigram’s current full-year earnings is $0.16 per share. Atb Cap Markets also issued estimates for Organigram’s Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.02) EPS and FY2025 earnings at ($0.10) EPS.

Other analysts also recently issued reports about the stock. Canaccord Genuity Group lowered their price target on shares of Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating on the stock in a report on Monday, December 9th. ATB Capital decreased their price objective on shares of Organigram from C$5.25 to C$3.50 in a research report on Tuesday, December 17th.

Get Our Latest Research Report on OGI

Organigram Stock Performance

Organigram stock opened at C$2.25 on Monday. The firm has a market cap of C$244.28 million, a PE ratio of -0.90, a P/E/G ratio of 0.42 and a beta of 1.13. Organigram has a 12 month low of C$1.67 and a 12 month high of C$3.95. The stock’s 50 day simple moving average is C$2.25 and its two-hundred day simple moving average is C$2.30. The company has a current ratio of 6.95, a quick ratio of 2.62 and a debt-to-equity ratio of 1.13.

Insider Activity at Organigram

In related news, Senior Officer Paolo De Luca sold 12,014 shares of the firm’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of C$2.52, for a total value of C$30,275.28. 31.32% of the stock is owned by corporate insiders.

Organigram Company Profile

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

Further Reading

Earnings History and Estimates for Organigram (TSE:OGI)

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.